Cell and Tissue Imaging Core
Cell and Tissue Imaging Core
批准号:
8709528
负责人:
William Paul Duprex
金额:
$2.92万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
已结题
起止时间:
至 2014-07-31
关键词:
AddressAgreementAnimalsBehaviorBiological ProductsBostonCategoriesCell physiologyCellsCellular MorphologyCollaborationsComputer softwareContainmentDecontaminationDevelopmentDimensionsEmerging Communicable DiseasesEnsureEquipmentExerciseGoalsHuman ResourcesImageImaging TechniquesInfectious AgentInfectious Diseases ResearchLaboratoriesLasersLifeLogisticsMicroscopeMicroscopyNational Institute of Allergy and Infectious DiseaseOrganellesPathogenesisProceduresRecoveryResearchResearch InfrastructureResearch PersonnelResearch Project GrantsResolutionRoleScanningScheduleServicesSpecimenSystemTechniquesTechnologyThree-Dimensional ImageTimeTissue SampleTissuesTrainingUniversitiesVisitWorkanimal tissuebioimagingcell fixingcostin vivoinformation gatheringoperationpathogenreconstructiontomographytrafficking
中文摘要
这一核心的总体目标是为宏观和
显微镜检查含有生物制剂的细胞和组织样本,这些生物制剂需要
遏制,直到细胞或组织样本处于中和和非感染状态。《细胞》
Neidl的组织成像核心(CTIC)将提供一系列成像系统进行分析
使用最先进技术的标本。几种高分辨率产品的可用性
显微镜平台将允许Neidl的研究人员从多探针、活细胞中收集信息
分析。这样的基础设施将帮助用户了解宿主细胞/病原体的相互作用和
允许对实验感染动物的感染组织进行有针对性的病理评估。
了解三维细胞和细胞器的断层扫描、互连和形态
(3D)在受感染的活体组织中对了解体内行为和
感染性病原体的发病机制。
国贸中心的业务目标是:
A.提供基础设施和专业知识,以可视化其细胞中的BSL-4病原体
在固定细胞、组织和动物中的上下文。
B.提供基础设施和专业知识,以可视化其细胞内的BSL-4病原体
随着时间的推移,固定细胞、组织和动物中的上下文。
C.与Neidl科学核心进行互动和合作,并为研究提供支持
处理NIAID A-C类优先病原体的项目。
D.对核心人员和Neidl附属研究人员进行生物成像技术培训。
英文摘要
The overall goal of this core is to provide the infrastructure and support to macroscopically and
microscopically examine cells and tissue specimens containing biological agents that require high
containment until the cell or tissue samples are in a neutralized and non-infectious state. The Cell
and Tissue Imaging Core (CTIC) at the NEIDL will offer a range of imaging systems to analyze
specimens using state-of-the-art technologies. The availability of several high resolution
microscopy platforms will allow NEIDL investigators to gather information from multi-probe, live cell
analyses. Such infrastructure will help users to understand the host cell/pathogen interactions and
permit targeted, pathological assessment of infected tissues from experimentally infected animals.
Knowing the tomography, interconnectivity and morphology of cells and organelles in three-dimensions
(3D) in living infected tissues is invaluable for understanding the in vivo behavior and
pathogenesis of infectious agents.
The operational goals of CITC are:
a. To provide the infrastructure and expertise to visualize BSL-4 pathogens in their cellular
context in fixed cells, tissues and animals.
b. To provide the infrastructure and expertise to visualize BSL-4 pathogens in their cellular
context in fixed cells, tissues, and animals over time.
c. To interact and collaborate with NEIDL scientific cores and to provide support to research
projects dealing with NIAID category A-C priority pathogens.
d. To train core personnel and NEIDL-affiliated researchers in bioimaging techniques.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Operations Core
-
批准号:10793943
-
项目类别:
-
资助金额:$98.46万
-
财政年份:2023
-
负责人:William Paul Duprex
-
依托单位:
Pitt RBL
-
批准号:10793942
-
项目类别:
-
资助金额:$287.02万
-
财政年份:2023
-
负责人:William Paul Duprex
-
依托单位:
Integrated Services Core
-
批准号:10793945
-
项目类别:
-
资助金额:$115.86万
-
财政年份:2023
-
负责人:William Paul Duprex
-
依托单位:
Practices Core
-
批准号:10793944
-
项目类别:
-
资助金额:$72.71万
-
财政年份:2023
-
负责人:William Paul Duprex
-
依托单位:
Administrative Supplement for Upgrading the University of Pittsburgh Regional Biocontainment Laboratory within The Center for Vaccine Research
-
批准号:10631339
-
项目类别:
-
资助金额:$332.97万
-
财政年份:2022
-
负责人:William Paul Duprex
-
依托单位:
Development of multivalent, ultrapotent nanobody cocktails for SARS-CoV-2 neutralization
-
批准号:10444442
-
项目类别:
-
资助金额:$76.9万
-
财政年份:2022
-
负责人:William Paul Duprex
-
依托单位:
Upgrading the University of Pittsburgh Regional Biocontainment Laboratory within The Center for Vaccine Research
-
批准号:10394474
-
项目类别:
-
资助金额:$333.0万
-
财政年份:2021
-
负责人:William Paul Duprex
-
依托单位:
Shifting a Paradigm in Vaccine Safety: From Empirical to Rational Attenuation
-
批准号:8664340
-
项目类别:
-
资助金额:$40.42万
-
财政年份:2013
-
负责人:William Paul Duprex
-
依托单位:
Shifting a Paradigm in Vaccine Safety: From Empirical to Rational Attenuation
-
批准号:8504483
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2013
-
负责人:William Paul Duprex
-
依托单位:
Shifting a Paradigm in Vaccine Safety: From Empirical to Rational Attenuation
-
批准号:9064740
-
项目类别:
-
资助金额:$40.93万
-
财政年份:2013
-
负责人:William Paul Duprex
-
依托单位:
Shifting a Paradigm in Vaccine Safety: From Empirical to Rational Attenuation
-
批准号:8852530
-
项目类别:
-
资助金额:$40.93万
-
财政年份:2013
-
负责人:William Paul Duprex
-
依托单位:
Shifting a Paradigm in Vaccine Safety: From Empirical to Rational Attenuation
-
批准号:9278078
-
项目类别:
-
资助金额:$40.93万
-
财政年份:2013
-
负责人:William Paul Duprex
-
依托单位:
Cell and Tissue Imaging Core
-
批准号:8307628
-
项目类别:
-
资助金额:$7.09万
-
财政年份:2011
-
负责人:William Paul Duprex
-
依托单位:
Cell and Tissue Imaging Core
-
批准号:8461424
-
项目类别:
-
资助金额:$10.78万
-
财政年份:2006
-
负责人:William Paul Duprex
-
依托单位:
海外基金